144 related articles for article (PubMed ID: 24446259)
1. HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies.
Zangarini M; Ceriani L; Bello E; Damia G; Cereda R; Camboni MG; Zucchetti M
J Mass Spectrom; 2014 Jan; 49(1):19-26. PubMed ID: 24446259
[TBL] [Abstract][Full Text] [Related]
2. Application of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to the pharmacokinetics, tissue distribution and excretion studies of felotaxel (SHR110008) in tumor-bearing mice.
Ding Y; Lu C; Yang J; Jin X; Yang L; Wang C; Ma Z; Zhu Y; Ding L; Jia Y; Wen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():61-6. PubMed ID: 22309773
[TBL] [Abstract][Full Text] [Related]
3. E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models.
Bello E; Colella G; Scarlato V; Oliva P; Berndt A; Valbusa G; Serra SC; D'Incalci M; Cavalletti E; Giavazzi R; Damia G; Camboni G
Cancer Res; 2011 Feb; 71(4):1396-405. PubMed ID: 21212416
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems.
Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Príeto MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4035-41. PubMed ID: 19896423
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of PD 0332991 in xenograft mouse tumor tissue by a 96-well supported liquid extraction format and liquid chromatography/mass spectrometry.
Nguyen L; Zhong WZ; Painter CL; Zhang C; Rahavendran SV; Shen Z
J Pharm Biomed Anal; 2010 Nov; 53(3):228-34. PubMed ID: 20236782
[TBL] [Abstract][Full Text] [Related]
6. A validated high-performance liquid chromatography-tandem mass spectrometry method for quantification of gefitinib and its main metabolites in xenograft mouse tumor: Application to a pharmacokinetics study.
Zhao C; Zheng N; Yang F; Han SY; Li PP
Biomed Chromatogr; 2019 Nov; 33(11):e4638. PubMed ID: 31261446
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an high performance liquid chromatography-tandem mass spectrometry method for the determination of imatinib in rat tissues.
Bianchi F; Caffarri E; Cavalli S; Lagrasta C; Musci M; Quaini F; Savi M
J Pharm Biomed Anal; 2013 Jan; 73():103-7. PubMed ID: 22709608
[TBL] [Abstract][Full Text] [Related]
8. Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry.
Zhao M; Hartke C; Jimeno A; Li J; He P; Zabelina Y; Hidalgo M; Baker SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):73-80. PubMed ID: 15797523
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study.
Sala F; Bagnati R; Livi V; Cereda R; D'Incalci M; Zucchetti M
J Mass Spectrom; 2011 Oct; 46(10):1039-45. PubMed ID: 22012670
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study.
Sala F; Zucchetti M; Bagnati R; D'Incalci M; Pace S; Capocasa F; Marangon E
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3118-26. PubMed ID: 19695967
[TBL] [Abstract][Full Text] [Related]
11. A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry.
Lin W; Huang MQ; Xue X; Bertelsen K; Chen G; Zhao H; Lin ZJ; Fourie A; de Jong J; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():54-62. PubMed ID: 23523878
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of ultra high performance liquid chromatography-mass spectrometry method for LBH589 in mouse plasma and tissues.
Estella-Hermoso de Mendoza A; Imbuluzqueta I; Campanero MA; Gonzalez D; Vilas-Zornoza A; Agirre X; Lana H; Abizanda G; Prosper F; Blanco-Prieto MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3490-6. PubMed ID: 21983199
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a rapid LC-MS/MS method for the determination of JCC76, a novel antitumor agent for breast cancer, in rat plasma and its application to a pharmacokinetics study.
Cai X; Zhong B; Su B; Xu S; Guo B
Biomed Chromatogr; 2012 Sep; 26(9):1118-24. PubMed ID: 22213194
[TBL] [Abstract][Full Text] [Related]
14. Sensitive liquid chromatography/tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue.
Zhang G; Terry AV; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):68-76. PubMed ID: 17452027
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
[TBL] [Abstract][Full Text] [Related]
16. HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model.
Ceriani L; Ferrari M; Zangarini M; Licandro SA; Bello E; Frapolli R; Falcetta F; D'Incalci M; Libener R; Grosso F; Aviles P; Zucchetti M
Bioanalysis; 2015; 7(15):1831-42. PubMed ID: 26295985
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatography analysis of a novel small-molecule, anti-cancer drug, Palomid 529, in human and mouse plasma and in mouse tissue homogenates.
Lin F; Sherris D; Beijnen JH; Van Tellingen O
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3823-31. PubMed ID: 22100549
[TBL] [Abstract][Full Text] [Related]
19. Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study.
Wade Calcutt M; Lee W; Puzanov I; Rothenberg ML; Hachey DL
J Mass Spectrom; 2008 Jan; 43(1):42-52. PubMed ID: 17683023
[TBL] [Abstract][Full Text] [Related]
20. Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry.
Deng Y; Wong H; Graham RA; Liu W; Shen HS; Shi Y; Wang L; Meng M; Malhi V; Ding X; Dean B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2119-26. PubMed ID: 21704573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
